Authors:
BUDMAN DR
MEROPOL NJ
REIGNER B
CREAVEN PJ
LICHTMAN SM
BERGHORN E
BEHR J
GORDON RJ
OSTERWALDER B
GRIFFIN T
Citation: Dr. Budman et al., PRELIMINARY STUDIES OF A NOVEL ORAL FLUOROPYRIMIDINE CARBAMATE - CAPECITABINE, Journal of clinical oncology, 16(5), 1998, pp. 1795-1802
Authors:
CREAVEN PJ
PENDYALA L
MEROPOL NJ
CLENDENINN NJ
WU EY
LOEWEN GM
PROEFROCK A
JOHNSTON A
DIXON M
Citation: Pj. Creaven et al., INITIAL CLINICAL-TRIAL AND PHARMACOKINETICS OF THYMITAQ(TM) (AG337) BY 10-DAY CONTINUOUS-INFUSION IN PATIENTS WITH ADVANCED SOLID TUMORS, Cancer chemotherapy and pharmacology, 41(2), 1998, pp. 167-170
Citation: Nj. Meropol et al., OCTREOTIDE DOES NOT PREVENT DIARRHEA IN PATIENTS TREATED WITH WEEKLY 5-FLUOROURACIL PLUS HIGH-DOSE LEUCOVORIN, American journal of clinical oncology, 21(2), 1998, pp. 135-138
Authors:
PENDYALA L
VELAGAPUDI S
TOTH K
ZDANOWICZ J
GLAVES D
SLOCUM H
PEREZ R
HUBEN R
CREAVEN PJ
RAGHAVAN D
Citation: L. Pendyala et al., TRANSLATIONAL STUDIES OF GLUTATHIONE IN BLADDER-CANCER CELL-LINES ANDHUMAN SPECIMENS, Clinical cancer research, 3(5), 1997, pp. 793-798
Authors:
SONI N
MEROPOL NJ
PENDYALA L
NOEL D
SCHACTER LP
GUNTON KE
CREAVEN PJ
Citation: N. Soni et al., PHASE-I AND PHARMACOKINETIC STUDY OF ETOPOSIDE PHOSPHATE BY PROTRACTED VENOUS INFUSION IN PATIENTS WITH ADVANCED CANCER, Journal of clinical oncology, 15(2), 1997, pp. 766-772
Authors:
CREAVEN PJ
PEREZ R
PENDYALA L
MEROPOL NJ
LOEWEN G
LEVINE E
BERGHORN E
RAGHAVAN D
Citation: Pj. Creaven et al., UNUSUAL CENTRAL-NERVOUS-SYSTEM TOXICITY IN A PHASE-I STUDY OF N(1)N(11)DIETHYLNORSPERMINE IN PATIENTS WITH ADVANCED MALIGNANCY, Investigational new drugs, 15(3), 1997, pp. 227-234
Authors:
CREAVEN PJ
RAGHAVAN D
PENDYALA L
LOEWEN G
KINDLER HL
BERGHORN EJ
Citation: Pj. Creaven et al., PACLITAXEL AND CARBOPLATIN IN EARLY PHASE STUDIES - ROSWELL-PARK-CANCER-INSTITUTE EXPERIENCE IN THE SUBSET OF PATIENTS WITH LUNG-CANCER, Seminars in oncology, 24(4), 1997, pp. 138-143
Authors:
MEROPOL NJ
PORTER M
BLUMENSON LE
LINDEMANN MJ
PEREZ RP
VAICKUS L
LOEWEN GM
CREAVEN PJ
WILKES KA
GIEDLIN MA
CALIGIURI MA
Citation: Nj. Meropol et al., DAILY SUBCUTANEOUS INJECTION OF LOW-DOSE INTERLEUKIN-2 EXPANDS NATURAL-KILLER-CELLS IN-VIVO WITHOUT SIGNIFICANT TOXICITY, Clinical cancer research, 2(4), 1996, pp. 669-677
Authors:
ELAKAWI Z
ZDANOWICZ J
CREAVEN PJ
ABUHADID M
PEREZ R
PENDYALA L
Citation: Z. Elakawi et al., INDUCTION OF GAMMA-GLUTAMYL-TRANSPEPTIDASE MESSENGER-RNA BY PLATINUM COMPLEXES IN A HUMAN OVARIAN-CARCINOMA CELL-LINE, Oncology research, 8(10-11), 1996, pp. 415-423
Authors:
MEROPOL NJ
RUSTUM YM
PETRELLI NJ
RODRIGUEZBIGAS M
FRANK C
HO DH
KUROWSKI M
CREAVEN PJ
Citation: Nj. Meropol et al., A PHASE-I AND PHARMACOKINETIC STUDY OF ORAL URACIL, FTORAFUR, AND LEUCOVORIN IN PATIENTS WITH ADVANCED CANCER, Cancer chemotherapy and pharmacology, 37(6), 1996, pp. 581-586
Authors:
CREAVEN PJ
RAGHAVAN D
PEREZ RP
PENDYALA L
BERGHORN EJ
LOEWEN G
MEROPOL NJ
Citation: Pj. Creaven et al., EARLY PHASE STUDIES WITH PACLITAXEL LOW-DOSE CARBOPLATIN IN PATIENTS WITH SOLID TUMORS/, Seminars in oncology, 23(6), 1996, pp. 26-31
Authors:
COOGAN MM
CREAVEN PJ
MACKOWN JM
GALPIN JS
Citation: Mm. Coogan et al., AN IMPRESSION TECHNIQUE AND CONVENTIONAL TESTS FOR PREDICTING CARIES ACTIVITY, Journal of dental research, 75(5), 1996, pp. 1307-1307
Citation: Nj. Meropol et al., SEIZURES ASSOCIATED WITH LEUCOVORIN ADMINISTRATION IN CANCER-PATIENTS, Journal of the National Cancer Institute, 87(1), 1995, pp. 56-58
Citation: L. Pendyala et Pj. Creaven, PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES OF N-ACETYLCYSTEINE, A POTENTIAL CHEMOPREVENTIVE AGENT DURING A PHASE-I TRIAL, Cancer epidemiology, biomarkers & prevention, 4(3), 1995, pp. 245-251
Authors:
PENDYALA L
CREAVEN PJ
PEREZ R
ZDANOWICZ JR
RAGHAVAN D
Citation: L. Pendyala et al., INTRACELLULAR GLUTATHIONE AND CYTOTOXICITY OF PLATINUM COMPLEXES, Cancer chemotherapy and pharmacology, 36(4), 1995, pp. 271-278
Authors:
MEROPOL NJ
PETRELLI NJ
RUSTUM YM
RODRIQUEZBIGAS M
BLUMENSON LE
FRANK C
BERGHORN E
CREAVEN PJ
Citation: Nj. Meropol et al., A PHASE-II AND PHARMACOKINETIC STUDY OF 6S-LEUCOVORIN PLUS 5-FLUOROURACIL IN PATIENTS WITH COLORECTAL-CARCINOMA, Investigational new drugs, 13(2), 1995, pp. 149-155
Citation: Nj. Meropol et al., METASTATIC COLORECTAL-CANCER - ADVANCES IN BIOCHEMICAL MODULATION ANDNEW DRUG DEVELOPMENT, Seminars in oncology, 22(5), 1995, pp. 509-524
Authors:
MATTHEW AM
CHRISTENSSON PI
SEIDEGARD J
TUVESSON H
BIBBY MC
HARTLEYASP B
CREAVEN PJ
Citation: Am. Matthew et al., EFFECT OF DRUG SCHEDULING ON THE ANTITUMOR-ACTIVITY AND BONE-MARROW TOXICITY OF TAUROMUSTINE (TCNU), International journal of oncology, 4(2), 1994, pp. 403-409
Authors:
CREAVEN PJ
RUSTUM YM
PETRELLI NJ
MEROPOL NJ
RAGHAVAN D
RODRIGUEZBIGAS M
LEVINE EG
FRANK C
UDVARYNAGY S
PROEFROCK A
Citation: Pj. Creaven et al., PHASE-I AND PHARMACOKINETIC EVALUATION OF FLOXURIDINE LEUCOVORIN GIVEN ON THE ROSWELL-PARK WEEKLY REGIMEN/, Cancer chemotherapy and pharmacology, 34(3), 1994, pp. 261-265
Citation: L. Pendyala et al., URINARY AND ERYTHROCYTE POLYAMINES DURING THE EVALUATION OF ORAL ALPHA-DIFLUOROMETHYLORNITHINE IN A PHASE-I CHEMOPREVENTION CLINICAL-TRIAL, Cancer epidemiology, biomarkers & prevention, 2(3), 1993, pp. 235-241
Citation: Pj. Creaven et al., EVALUATION OF ALPHA-DIFLUOROMETHYLORNITHINE AS A POTENTIAL CHEMOPREVENTIVE AGENT - TOLERANCE TO DAILY ORAL-ADMINISTRATION IN HUMANS, Cancer epidemiology, biomarkers & prevention, 2(3), 1993, pp. 243-247
Authors:
MANZUIK LV
PEREVODCHIKOVA NI
GORBUNOVA VA
SINGIN AS
GERASIMOVA GS
BYCHKOV MB
RUSTUM YM
CREAVEN PJ
Citation: Lv. Manzuik et al., INITIAL CLINICAL-EXPERIENCE WITH ORAL FTORAFUR AND ORAL-6R, S-LEUCOVORIN IN ADVANCED COLORECTAL-CARCINOMA, European journal of cancer, 29A(12), 1993, pp. 1793-1794